BDBM72305 3-(4-acetoxyphenyl)benzoic acid [2-keto-2-(N-methylanilino)ethyl] ester::3-(4-acetyloxyphenyl)benzoic acid [2-(N-methylanilino)-2-oxoethyl] ester::MLS000390678::SMR000259716::[2-(N-methylanilino)-2-oxoethyl] 3-(4-acetyloxyphenyl)benzoate::[2-[methyl(phenyl)amino]-2-oxidanylidene-ethyl] 3-(4-acetyloxyphenyl)benzoate::cid_2336309

SMILES O=C1c2cc(C(F)(F)F)ccc2N2CN1c1ccc(=O)[nH]c1NCCCc1cc(F)ccc12

InChI Key InChIKey=OOBCDWJQRBOVTR-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72305   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72305BDBM72305(8-Fluoro-2-(trifluoromethyl)-10,11,12,13-tetrahydr...)
Affinity DataIC50: 15.8nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
US Patent